Long-term renal function and cardiovascular disease risk in obese kidney donors

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 7, 2009, Pages 1230-1238

  Tavakol, Mohammad M ^a   Vincenti, Flavio G ^b   Assadi, Hamid ^a   Frederick, Michael J ^a   Tomlanovich, Stephen J ^b   Roberts, John P ^a   Posselt, Andrew M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DONOR; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OBESITY; POSTOPERATIVE CARE; PREOPERATIVE EDUCATION; ALBUMINURIA; DYSLIPIDEMIA; INCIDENCE; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; LIVING DONOR; MIDDLE AGED; RENOVASCULAR HYPERTENSION; RISK FACTOR; STATISTICS; UNITED STATES;

ADULT; ALBUMINURIA; CALIFORNIA; COMORBIDITY; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION, RENAL; INCIDENCE; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; OBESITY; RISK FACTORS;

EID: 70349309978     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01350209     Document Type: Article

References (44)

1. US Renal Data System: USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
2. Miller IJ, Suthanthiran M, Riggio RR, Williams JJ, Riehle RA, Vaughhan ED, Stubenbord WT, Mouradian J, Cheigh JS, Stenzel KH: Impact of renal donation, long-term clinical and biochemical follow-up of living donors in a single center. Am J Med 79: 201-208, 1985
3. Davis CL, Delmonico FL: Living donor kidney transplantation: A review of the current practice for the live donor. J Am Soc Nephrol 16: 2098-2110, 2005
4. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL: Obesity and target organ damage: The kidney. Int J Obes 26: S21-S24, 2002
5. Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, Tallam L: Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 11: 41-54, 2004
6. Hsu C, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006
7. National Center for Health Statistics, National Health and Nutrition Examination Survey 2005-2006. Available at: http://www.cdc.gov/nchs/about/major/ nhanes/nhanes2005-2006/nhanes05-06.htm. Accessed November 13, 2008.
8. Chobanian AV, Bakris GL, Cushman WC, Black HR, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT: Seventh report of the National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2003
9. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555, 2006
10. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L: Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med 138: 24-32, 2003
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
12. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function: Measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483, 2006
13. Keane WF, Eknoyan G: Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 33: 1004-1010, 1999
14. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49[Suppl 2]: S12-S154, 2007
15. Grundy SM: Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 25: 2243-2244, 2005
16. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H,. Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847, 1998
17. Textor S, Taler S: Expanding criteria for living kidney donors: What are the limits? Transpl Rev 22: 187-191, 2008
18. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor J, Griffin M, Cosio F, Schwab T, Prieto M, Nyberg S, Ishitani M, Stegall M: Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 78: 276-282, 2004
19. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow JK, Ishitani MB, Larson TS, Stegall MD: Obesity in living kidney donors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 5: 1057-1064, 2005
20. Jacobs SC, Cho E, Dunkin BJ, Bartlett ST, Flowers JL, Jarrell B, Jacobs SC: Laparoscopic nephrectomy in the markedly obese living renal donor. Urology 56: 926-929, 2000
21. Gossmann J, Wilhelm A, Kachel HG, Jordan J, Sann U, Geiger H, Kramer W, Scheuermann EH: Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center. Am J Transplant 5: 2417-2424, 2005
22. Carter JT, Freise CE, McTaggart RA, Mahanty HD, Kang SM, Posselt AM: Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient. Am J Transplant 5: 1312-1318, 2005
23. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Engl J Med 347: 305-313, 2002
24. Hall JE: The kidney, hypertension, and obesity. Hypertension 41: 625-633, 2003
25. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001
26. Praga M, Hernandez E, Herrero JC, Morales E, Revilla Y, Diaz-Gonzales R, Rodicio JL: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58: 2111-2118, 2000
27. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y: The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14: 1480-1486, 2003
28. Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, Rolin HA, Flechner S, Goormastic M, Novick AC: Renal outcome 25 years after donor nephrectomy. J Urol 166: 2043-2047, 2001
29. Ramcharan T, Matas AJ: Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant 2: 959-964, 2002
30. Sommerer C, Morath C, Andrassy J, Zeier M: The longterm consequences of living-related or unrelated kidney donation. Nephrol Dial Transplant 19: iv45-iv47, 2004
31. Gaspari F, Perico N, Matalone M, Signorini O, Azzollini N, Mister M, Remuzzi G: Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol 9: 310-313, 1998
32. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56: 2214-2219, 1999
33. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S, HOPE investigators: Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
34. Schillaci G, Reboldi G, Verdecchia P: High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 161: 886-891, 2001
35. Shlipak MG, Praught ML, Sarnak MJ: Update on cystatin C: New insight into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens 15: 270 -275, 2006
36. Najarian JS, Chavers BM, McHugh Le, Matas AJ: 20 years or more of follow-up of living kidney donors. Lancet 340: 807-810, 1992
37. Rizvi SA, Naqvi SA, Jawad F, Ahmed E, Asghar A, Zafar MN, Akhtar F: Living kidney donor follow-up in a dedicated clinic. Transplantation 79: 1247-1251, 2005
38. Textor SC, Taler SJ, Larson TS, Prieto M, Griffin M, Gloor J, Nyberg S, Velosa J, Schwab T, Stegall M. Blood pressure elevation among older living kidney donors. J Am Soc Nephrol 14: 2159-2167, 2003
39. Kronenberg F, Kuen E, Ritz E Junker R, Konig P, Kraatz G, Lhotta K, Mann J, Muller GA, Neyer U, Riegel W, Riegler P, Schwenger V, Von Eckardstein A. Lipoprotein (a) serum concentrations and apolipoprotein (a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 11: 105-115, 2000
40. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA: High density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 79: 8-15, 1989
41. Pedersen TR, Olsson AG, Færgeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyorala K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ: Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian simvastatin survival study (4S). Circulation 97: 1453-1460, 1998
42. The lipid research clinics coronary primary prevention trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365-374, 1984
43. Mandelbrot DA, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Rodrigue JR: The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 7: 2333-2343, 2007
44. Ford ES, Mokdad AH: Epidemiology of obesity in the western hemisphere. J Clin Endocrinol Metab 93: S1-S8, 2008